Hospital Medicine News

Data from Los Angeles County during the omicron surge showed that the COVID-19 hospitalization rate was 23 times higher among people who were unvaccinated compared with people who had received a COVID-19 vaccine series and booster.

A phase 2 trial will evaluate if temporarily reducing the immunosuppressive medication of transplant recipients in the days before and after they receive an additional dose of COVID-19 vaccine increases their immune response to the vaccine.

The global response to the COVID-19 pandemic has produced tens of thousands of tons of extra health care waste that many facilities are not equipped to handle, according to WHO.

Novavax on Monday announced that it has submitted an emergency use authorization request to the FDA for its protein-based COVID-19 vaccine for individuals aged 18 years or older.

Intent-to-treat survival among pediatric patients who have received a heart, liver or kidney transplant steadily improved over the past 3 decades, according to a study of more than 47,000 transplants.

Researchers identified four factors that may anticipate if a patient will develop long COVID.

Waiting more than 5 hours in an ED before hospital admission was linked to an increased risk for death from any cause in the 30 days that followed, according to findings published in the Emergency Medicine Journal.

Moderna on Wednesday announced the start of a phase 2 study of an omicron-specific COVID-19 booster shot.

The New England Journal of Medicine on Wednesday published data from the ongoing NIH-sponsored trial that led the FDA last fall to authorize the mix-and-match strategy for COVID-19 vaccine boosters.

Of more than 3,000 lung transplants performed in the U.S. from August 2020 to Sept. 30, 2021, 7% were performed to treat severe, irreversible lung damage caused by COVID-19, researchers reported in The New England Journal of Medicine.